Abstract
Lisa Nodzon PhD, APRN, AOCNP®, of Moffitt Cancer Center, reviews data on clinical trials and future directions in BCMA-directed CAR T cells presented in a session by Jesus G. Berdeja, MD, of Sarah Cannon Cancer Institute, at the 2021 SOHO Annual Meeting.
